股票 › UTHR
联合治疗公司 UTHR
美股市值排名 #825
$562.02 −$3.70 (-0.65%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $562.02 0.00%
开盘$561.95
昨收$565.72
当日区间$559.41 – $569.45
成交量468.6K
市值$23.94B
市盈率（TTM）21.2
股息率–
UTHR 相关新闻
匹配 United Therapeutics 或代码 UTHR 的头条新闻，按最新排序。
- Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $704 负面
- United Therapeutics(UTHR.US) Officer Sells US$4.57 Million in Common Stock
- United Therapeutics(UTHR.US) Officer Sells US$4.52 Million in Common Stock
- United Therapeutics(UTHR.US) Officer Sells US$4.5 Million in Common Stock
- Goldman Sachs Initiates United Therapeutics(UTHR.US) With Sell Rating, Announces Target Price $321
- Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $700
- TD Cowen Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $675
- H.C. Wainwright Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $660
- RBC Capital Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $677 负面
- Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $700 负面
- RBC Capital Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $704 正面
- Wells Fargo Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $738
- J.P. Morgan Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $687 正面
- Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Cuts Target Price to $714 负面
- BofA Securities Maintains United Therapeutics(UTHR.US) With Hold Rating, Cuts Target Price to $613 负面
暂无评论——快来第一个聊聊 UTHR。
登录后参与讨论。